Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer.
Wu Y, Jennings NB, Sun Y, Dasari SK, Bayraktar E, Corvigno S, Stur E, Glassman D, Mangala LS, Lankenau Ahumada A, Westin SN, Sood AK, Hu W. Wu Y, et al. Among authors: jennings nb. J Cancer Res Clin Oncol. 2022 Apr;148(4):803-821. doi: 10.1007/s00432-021-03885-z. Epub 2022 Jan 30. J Cancer Res Clin Oncol. 2022. PMID: 35094142 Free PMC article.
Functional significance of VEGFR-2 on ovarian cancer cells.
Spannuth WA, Nick AM, Jennings NB, Armaiz-Pena GN, Mangala LS, Danes CG, Lin YG, Merritt WM, Thaker PH, Kamat AA, Han LY, Tonra JR, Coleman RL, Ellis LM, Sood AK. Spannuth WA, et al. Among authors: jennings nb. Int J Cancer. 2009 Mar 1;124(5):1045-53. doi: 10.1002/ijc.24028. Int J Cancer. 2009. PMID: 19058181 Free PMC article.
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
Halder J, Kamat AA, Landen CN Jr, Han LY, Lutgendorf SK, Lin YG, Merritt WM, Jennings NB, Chavez-Reyes A, Coleman RL, Gershenson DM, Schmandt R, Cole SW, Lopez-Berestein G, Sood AK. Halder J, et al. Among authors: jennings nb. Clin Cancer Res. 2006 Aug 15;12(16):4916-24. doi: 10.1158/1078-0432.CCR-06-0021. Clin Cancer Res. 2006. PMID: 16914580 Free PMC article.
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma.
Kim TJ, Ravoori M, Landen CN, Kamat AA, Han LY, Lu C, Lin YG, Merritt WM, Jennings N, Spannuth WA, Langley R, Gershenson DM, Coleman RL, Kundra V, Sood AK. Kim TJ, et al. Cancer Res. 2007 Oct 1;67(19):9337-45. doi: 10.1158/0008-5472.CAN-06-4018. Cancer Res. 2007. PMID: 17909042
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
Mangala LS, Zuzel V, Schmandt R, Leshane ES, Halder JB, Armaiz-Pena GN, Spannuth WA, Tanaka T, Shahzad MM, Lin YG, Nick AM, Danes CG, Lee JW, Jennings NB, Vivas-Mejia PE, Wolf JK, Coleman RL, Siddik ZH, Lopez-Berestein G, Lutsenko S, Sood AK. Mangala LS, et al. Among authors: jennings nb. Clin Cancer Res. 2009 Jun 1;15(11):3770-80. doi: 10.1158/1078-0432.CCR-08-2306. Epub 2009 May 26. Clin Cancer Res. 2009. PMID: 19470734 Free PMC article.
Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models.
Lu C, Shahzad MM, Moreno-Smith M, Lin YG, Jennings NB, Allen JK, Landen CN, Mangala LS, Armaiz-Pena GN, Schmandt R, Nick AM, Stone RL, Jaffe RB, Coleman RL, Sood AK. Lu C, et al. Among authors: jennings nb. Cancer Biol Ther. 2010 Feb;9(3):176-82. doi: 10.4161/cbt.9.3.10635. Epub 2010 Feb 16. Cancer Biol Ther. 2010. PMID: 20009575 Free PMC article.
78 results